Company Overview of Therapix Biosciences Ltd.
Therapix Biosciences Ltd. develops improved immunotherapeutics in Israel. The company is developing oral anti-CD3 monoclonal antibody (MAb), an immunotherapeutic for treating inflammatory and autoimmune diseases, such as nonalcoholic steatohepatitis, Hepatitis C, and ulcerative colitis; and BBS MAb, an immunotherapeutic for Alzheimer's disease. Therapix Biosciences Ltd. is based in Ness Ziona, Israel.
18 Einstein Street
Ness Ziona, 11013
972 8 939 6577
972 8 939 6574
Key Executives for Therapix Biosciences Ltd.
Therapix Biosciences Ltd. does not have any Key Executives recorded.
Therapix Biosciences Ltd. Key Developments
Similar Private Companies By Industry
|Beta-O2 Technologies Ltd.||Middle East/Africa|
|Savicell Diagnostic Ltd.||Middle East/Africa|
|Allosterix Ltd.||Middle East/Africa|
|Balm Pharmaceuticals Ltd.||Middle East/Africa|
|Biosan Ltd.||Middle East/Africa|
Recent Private Companies Transactions
April 2, 2014
December 23, 2013
December 4, 2013
To contact Therapix Biosciences Ltd., please visit www.nasvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.